PalindromeLab collects tokenized DNA and RNA sequencing data at scale — no patient names, no identifiers, no HIPAA complexity. Every profile we gather trains a more precise, more complete AI understanding of human biology. We partner with CLIA-certified sequencing labs to make it happen.
Precision medicine has been limited by one problem: the data needed to train truly precise AI has always been locked behind patient privacy walls. You can't build a comprehensive biological intelligence on anonymized population averages.
PalindromeLab solves this with cryptographic token architecture. We collect rich genomic and RNA sequencing data — DNA variants, gene expression profiles, exosome markers, ribosome activity — paired only to mathematical tokens, not to any person. The patient holds the connection. We receive only the science.
Every tokenized profile we gather teaches our AI — Hypatia — to understand human biology at a resolution that has never been possible before. We are building the dataset that makes truly personalized medicine real.
We collect across the full spectrum of genomic science — from static DNA variants to real-time RNA expression — building a multi-dimensional biological intelligence that no single data type could support alone.
The static blueprint — single nucleotide variants, copy number variations, structural variants, and allelic configurations across 18,000+ clinically relevant markers. WGS, WES, and targeted gene panels all accepted.
The living layer — which genes are actually being expressed, at what level, and in response to what signals. Whole-transcriptome RNA-seq captures the full expression landscape, revealing how the genome is being used in real time.
Exosomes carry biological messages between cells — small RNAs, miRNAs, and proteins that reveal systemic cellular communication. Liquid biopsy exosome sequencing gives us a real-time window into cellular signaling without any tissue sampling.
Ribosome profiling (Ribo-seq) measures which mRNAs are actively being translated into proteins, when, and at what efficiency. This captures the mTOR pathway, protein synthesis rates, and translational regulation — the engine that converts genetic potential into cellular reality.
This isn't a privacy policy layered on top of an unsafe system. It's a fundamental architectural decision: genomic and RNA data lives in a completely separate system from patient identity. They are connected only by a cryptographic token — a mathematical key held exclusively by the individual.
PalindromeLab receives sequencing data paired to tokens. We cannot reverse the token to a name. Even if compelled, even if breached — there is no name to produce. The genomic intelligence we collect and train on is permanently de-linked from any individual human being.
We don't ask you to change your workflow. You receive a kit with a token ID, sequence it with your existing CLIA-certified process, and return the data to the token. That's the entire engagement.
Receive a collection kit labeled with a token ID only. Run your existing sequencing protocols — WGS, WES, RNA-seq, exosome, Ribo-seq. Return variant and expression data via our secure API.
No BAA required. No PHI ever handled. Your lab's CLIA accreditation applies exactly as normal. Our legal team has reviewed this architecture — the answer is consistently: you're just sequencing samples, not handling patient data.
Net-30 per-sample payment for every result delivered. Volume tiers unlock higher rates automatically. No renegotiation required as your contribution scales.
We accept all sequencing modalities: WGS, WES, targeted panels, bulk RNA-seq, single-cell RNA-seq, long-read RNA, exosome profiling, and ribosome profiling. The more modalities your lab supports, the more valuable your contribution.
CLIA certification is our primary requirement for US labs. International equivalents (ISO 15189, CAP-equivalent accreditation) are accepted. We have partnerships with labs across North America, Europe, and Southeast Asia.
The data your lab contributes directly trains AI that will eventually guide personalized health decisions for millions of people. This isn't routine processing — it's foundational science.
No volume commitment to begin. Our agreements expand with you automatically.
Tell us about your lab and sequencing capabilities. We respond within one business day.